메뉴 건너뛰기




Volumn 22, Issue 8, 2014, Pages 2197-2206

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

Author keywords

Anaemia; Chemotherapy induced anaemia; Diagnosis; Erythropoiesis stimulating agents; Intravenous iron; Iron deficiency

Indexed keywords

ANTINEOPLASTIC AGENT; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

EID: 84905118024     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2189-0     Document Type: Article
Times cited : (32)

References (43)
  • 2
    • 84883788244 scopus 로고    scopus 로고
    • Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
    • Ludwig H, Muldur E, Endler G, Hubl W (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 24:1886-1892
    • (2013) Ann Oncol , vol.24 , pp. 1886-1892
    • Ludwig, H.1    Muldur, E.2    Endler, G.3    Hubl, W.4
  • 3
    • 0037102975 scopus 로고    scopus 로고
    • Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
    • DOI 10.1002/cncr.10763
    • Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB et al (2002) Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95:888-895 (Pubitemid 34839682)
    • (2002) Cancer , vol.95 , Issue.4 , pp. 888-895
    • Crawford, J.1    Cella, D.2    Cleeland, C.S.3    Cremieux, P.-Y.4    Demetri, G.D.5    Sarokhan, B.J.6    Slavin, M.B.7    Glaspy, J.A.8
  • 4
    • 42949127743 scopus 로고    scopus 로고
    • Anaemia of cancer: An overview of mechanisms involved in its pathogenesis
    • Grotto HZ (2008) Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol 25:12-21
    • (2008) Med Oncol , vol.25 , pp. 12-21
    • Grotto, H.Z.1
  • 5
    • 84864955819 scopus 로고    scopus 로고
    • Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron
    • Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Ann Oncol 23:1954-1962
    • (2012) Ann Oncol , vol.23 , pp. 1954-1962
    • Aapro, M.1    Osterborg, A.2    Gascon, P.3    Ludwig, H.4    Beguin, Y.5
  • 6
    • 0036854276 scopus 로고    scopus 로고
    • Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients
    • Beguin Y (2002) Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients. Haematologica 87:1209-1221
    • (2002) Haematologica , vol.87 , pp. 1209-1221
    • Beguin, Y.1
  • 8
    • 0035366382 scopus 로고    scopus 로고
    • Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
    • Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH (2001) Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19:2875-2882 (Pubitemid 32538197)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.11 , pp. 2875-2882
    • Gabrilove, J.L.1    Cleeland, C.S.2    Livingston, R.B.3    Sarokhan, B.4    Winer, E.5    Einhorn, L.H.6
  • 9
    • 0035367087 scopus 로고    scopus 로고
    • Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
    • Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19:2865-2874 (Pubitemid 32538196)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.11 , pp. 2865-2874
    • Littlewood, T.J.1    Bajetta, E.2    Nortier, J.W.R.3    Vercammen, E.4    Rapoport, B.5
  • 10
    • 66149150959 scopus 로고    scopus 로고
    • Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study
    • Ludwig H, Aapro M, Bokemeyer C, MacDonald K, Soubeyran P, Turner M, Albrecht Tet al (2009) Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. Eur J Cancer 45:1603-1615
    • (2009) Eur J Cancer , vol.45 , pp. 1603-1615
    • Ludwig, H.1    Aapro, M.2    Bokemeyer, C.3    MacDonald, K.4    Soubeyran, P.5    Turner, M.A.T.A.6
  • 12
    • 58149300172 scopus 로고    scopus 로고
    • Patient blood management: The pragmatic solution for the problems with blood transfusions
    • Spahn DR, Moch H, Hofmann A, Isbister JP (2008) Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 109:951-953
    • (2008) Anesthesiology , vol.109 , pp. 951-953
    • Spahn, D.R.1    Moch, H.2    Hofmann, A.3    Isbister, J.P.4
  • 14
    • 84890880838 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network Inc (28 August 2013, date last accessed)
    • National Comprehensive Cancer Network Inc (2014) NCCN practice guidelines in oncology: cancer and chemotherapy-induced anemia - v.2. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#supportive (28 August 2013, date last accessed).
    • (2014) NCCN Practice Guidelines in Oncology: Cancer and Chemotherapy-induced Anemia - V.2
  • 16
    • 78549286047 scopus 로고    scopus 로고
    • American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
    • Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL et al (2010) American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116:4045-4059
    • (2010) Blood , vol.116 , pp. 4045-4059
    • Rizzo, J.D.1    Brouwers, M.2    Hurley, P.3    Seidenfeld, J.4    Arcasoy, M.O.5    Spivak, J.L.6    Bennett, C.L.7
  • 17
    • 49249083689 scopus 로고    scopus 로고
    • September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents
    • Aapro MS, Link H (2008) September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 13(Suppl 3):33-36
    • (2008) Oncologist , vol.13 , Issue.SUPPL. 3 , pp. 33-36
    • Aapro, M.S.1    Link, H.2
  • 18
    • 67749150832 scopus 로고    scopus 로고
    • Canadian supportive care recommendations for the management of anemia in patients with cancer
    • Mikhael J, Melosky B, Cripps C, Rayson D, Kouroukis CT (2007) Canadian supportive care recommendations for the management of anemia in patients with cancer. Curr Oncol 14:209-217
    • (2007) Curr Oncol , vol.14 , pp. 209-217
    • Mikhael, J.1    Melosky, B.2    Cripps, C.3    Rayson, D.4    Kouroukis, C.T.5
  • 19
    • 84905085225 scopus 로고    scopus 로고
    • Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia
    • Dirix L, Awada D, Bron D, Canon JL, De Grève J, Humblet Y, Peeters M et al (2010) Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia. Belg J Med Oncol 4:57-64
    • (2010) Belg J Med Oncol , vol.4 , pp. 57-64
    • Dirix, L.1    Awada, D.2    Bron, D.3    Canon, J.L.4    De Grève, J.5    Humblet, Y.6    Peeters, M.7
  • 20
    • 77954319713 scopus 로고    scopus 로고
    • Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
    • Schrijvers D, De SH, Roila F (2010) Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol 21(Suppl 5):v244-v247
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5
    • Schrijvers, D.1    De, S.H.2    Roila, F.3
  • 21
    • 2142825053 scopus 로고    scopus 로고
    • Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
    • DOI 10.1200/JCO.2004.08.119
    • Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, Balan S et al (2004) Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22:1301-1307 (Pubitemid 41079845)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.7 , pp. 1301-1307
    • Auerbach, M.1    Ballard, H.2    Trout, J.R.3    McIlwain, M.4    Ackerman, A.5    Bahrain, H.6    Balan, S.7    Barker, L.8    Rana, J.9
  • 22
    • 77956453903 scopus 로고    scopus 로고
    • Darbepoetin alfa 300 or 500 ug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
    • Auerbach M, Silberstein PT, Webb RT, Averyanova S, Ciuleanu TE, Shao J, Bridges K (2010) Darbepoetin alfa 300 or 500 ug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. Am J Hematol 85:655-663
    • (2010) Am J Hematol , vol.85 , pp. 655-663
    • Auerbach, M.1    Silberstein, P.T.2    Webb, R.T.3    Averyanova, S.4    Ciuleanu, T.E.5    Shao, J.6    Bridges, K.7
  • 23
    • 43249129663 scopus 로고    scopus 로고
    • Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
    • Bastit L, Vandebroek A, Altintas S, Gaede B, Pinter T, Suto TS, Mossman TWet al (2008) Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. J Clin Oncol 26:1611-1618
    • (2008) J Clin Oncol , vol.26 , pp. 1611-1618
    • Bastit, L.1    Vandebroek, A.2    Altintas, S.3    Gaede, B.4    Pinter, T.5    Suto, T.S.M.T.A.6
  • 24
    • 33947405774 scopus 로고    scopus 로고
    • Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: A randomized multicenter study
    • DOI 10.1038/sj.leu.2404562, PII 2404562
    • Hedenus M, Birgegard G, Nasman P, Ahlberg L, Karlsson T, Lauri B, Lundin J et al (2007) Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study. Leukemia 21:627-632 (Pubitemid 46444544)
    • (2007) Leukemia , vol.21 , Issue.4 , pp. 627-632
    • Hedenus, M.1    Birgegard, G.2    Nasman, P.3    Ahlberg, L.4    Karlsson, T.5    Lauri, B.6    Lundin, J.7    Larfars, G.8    Osterborg, A.9
  • 25
    • 33847046008 scopus 로고    scopus 로고
    • Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
    • Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR (2007) Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 12:231-242
    • (2007) Oncologist , vol.12 , pp. 231-242
    • Henry, D.H.1    Dahl, N.V.2    Auerbach, M.3    Tchekmedyian, S.4    Laufman, L.R.5
  • 26
    • 43249121140 scopus 로고    scopus 로고
    • Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
    • Pedrazzoli P, Farris A, Del PS, Del GF, Ferrari D, Bianchessi C, Colucci G et al (2008) Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. J Clin Oncol 26:1619-1625
    • (2008) J Clin Oncol , vol.26 , pp. 1619-1625
    • Pedrazzoli, P.1    Farris, A.2    Del, P.S.3    Del, G.F.4    Ferrari, D.5    Bianchessi, C.6    Colucci, G.7
  • 27
    • 84871400455 scopus 로고    scopus 로고
    • Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials
    • Gafter-Gvili A, Rozen-Zvi B, Vidal L, Leibovici L, Vansteenkiste J, Gafter U, Shpilberg O (2013) Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials. Acta Oncol 52:18-29
    • (2013) Acta Oncol , vol.52 , pp. 18-29
    • Gafter-Gvili, A.1    Rozen-Zvi, B.2    Vidal, L.3    Leibovici, L.4    Vansteenkiste, J.5    Gafter, U.6    Shpilberg, O.7
  • 28
    • 84888060950 scopus 로고    scopus 로고
    • Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial
    • Beguin Y, Maertens J, De PB, Schots R, Seidel L, Bonnet C, Hafraoui K et al. (2013) Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. Am J Hematol
    • (2013) Am J Hematol
    • Beguin, Y.1    Maertens, J.2    De, P.B.3    Schots, R.4    Seidel, L.5    Bonnet, C.6    Hafraoui, K.7
  • 29
    • 79957919298 scopus 로고    scopus 로고
    • Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: Comparison of Europe and North America
    • Bailie GR, Horl WH, Verhof JJ (2011) Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. Drug Res 61:267-275
    • (2011) Drug Res , vol.61 , pp. 267-275
    • Bailie, G.R.1    Horl, W.H.2    Verhof, J.J.3
  • 30
    • 65949085753 scopus 로고    scopus 로고
    • The pharmacology and safety profile of ferric carboxymaltose (Ferinject®): Structure/reactivity relationships of iron preparations
    • Geisser P (2009) The pharmacology and safety profile of ferric carboxymaltose (Ferinject®): structure/reactivity relationships of iron preparations. Port J Nephrol Hypert 23:11-16
    • (2009) Port J Nephrol Hypert , vol.23 , pp. 11-16
    • Geisser, P.1
  • 32
    • 84867506589 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for anemia in chronic kidney disease
    • Kidney disease: Improving global outcomes (KDIGO) anemia work group
    • Kidney disease: Improving global outcomes (KDIGO) anemia work group (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney inter, Suppl 2:279-335
    • (2012) Kidney Inter , Issue.SUPPL. 2 , pp. 279-335
  • 33
    • 79951986687 scopus 로고    scopus 로고
    • Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia
    • Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ et al (2011) Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol 29:97-105
    • (2011) J Clin Oncol , vol.29 , pp. 97-105
    • Steensma, D.P.1    Sloan, J.A.2    Dakhil, S.R.3    Dalton, R.4    Kahanic, S.P.5    Prager, D.J.6    Stella, P.J.7
  • 35
    • 84873831349 scopus 로고    scopus 로고
    • Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
    • Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H et al (2013) Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Ann Oncol 24:475-482
    • (2013) Ann Oncol , vol.24 , pp. 475-482
    • Steinmetz, T.1    Tschechne, B.2    Harlin, O.3    Klement, B.4    Franzem, M.5    Wamhoff, J.6    Tesch, H.7
  • 36
    • 33947312849 scopus 로고    scopus 로고
    • Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy
    • DOI 10.1016/j.ygyno.2006.11.014, PII S0090825806009292
    • Kim YT, Kim SW, Yoon BS, Cho HJ, Nahm EJ, Kim SH, Kim JH et al (2007) Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 105:199-204 (Pubitemid 46441460)
    • (2007) Gynecologic Oncology , vol.105 , Issue.1 , pp. 199-204
    • Kim, Y.T.1    Kim, S.W.2    Yoon, B.S.3    Cho, H.J.4    Nahm, E.J.5    Kim, S.H.6    Kim, J.H.7    Kim, J.W.8
  • 37
    • 75749138424 scopus 로고    scopus 로고
    • Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy
    • Dangsuwan P, Manchana T (2010) Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol 116:522-525
    • (2010) Gynecol Oncol , vol.116 , pp. 522-525
    • Dangsuwan, P.1    Manchana, T.2
  • 38
    • 84888301208 scopus 로고    scopus 로고
    • Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy
    • Athibovonsuk P, Manchana T, Sirisabya N (2013) Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol 131:679-682
    • (2013) Gynecol Oncol , vol.131 , pp. 679-682
    • Athibovonsuk, P.1    Manchana, T.2    Sirisabya, N.3
  • 39
    • 84905101985 scopus 로고    scopus 로고
    • Intravenous ferric carboxymaltose as sole anemia therapy in patients with lymphoid malignancies, chemotherapy-induced anemia and functional iron deficiency. (poster)
    • Hedenus M, Karlsson T, Ludwig H, Felder M, Roubert B, Birgegard G (2013) Intravenous ferric carboxymaltose as sole anemia therapy in patients with lymphoid malignancies, chemotherapy-induced anemia and functional iron deficiency. ASH Annual Meeting Abstracts. 3439 (poster)
    • (2013) ASH Annual Meeting Abstracts , vol.3439
    • Hedenus, M.1    Karlsson, T.2    Ludwig, H.3    Felder, M.4    Roubert, B.5    Birgegard, G.6
  • 40
    • 84855986249 scopus 로고    scopus 로고
    • Management of anemia in cancer patients: Transfusions
    • Schrijvers D (2011)Management of anemia in cancer patients: transfusions. Oncologist 16(Suppl 3):12-18
    • (2011) Oncologist , vol.16 , Issue.SUPPL. 3 , pp. 12-18
    • Schrijvers, D.1
  • 41
    • 84855757596 scopus 로고    scopus 로고
    • Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management
    • Hofmann A, Farmer S, Shander A (2011) Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist 16(Suppl 3):3-11
    • (2011) Oncologist , vol.16 , Issue.SUPPL. 3 , pp. 3-11
    • Hofmann, A.1    Farmer, S.2    Shander, A.3
  • 42
    • 83255187145 scopus 로고    scopus 로고
    • Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe study
    • Spielmann M, Luporsi E, Ray Coquard I, De BS, Azria D, Lasocki S, Lafuma A et al (2012) Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study. Eur J Cancer 48:101-107
    • (2012) Eur J Cancer , vol.48 , pp. 101-107
    • Spielmann, M.1    Luporsi, E.2    Ray Coquard, I.3    De, B.S.4    Azria, D.5    Lasocki, S.6    Lafuma, A.7
  • 43
    • 84878228573 scopus 로고    scopus 로고
    • Treatment of cancer-associated anaemia: Results froma two-day cross-sectional survey in Germany
    • Link H, Schmitz S (2013) Treatment of cancer-associated anaemia: results froma two-day cross-sectional survey in Germany. Onkologie 36:266-272
    • (2013) Onkologie , vol.36 , pp. 266-272
    • Link, H.1    Schmitz, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.